Statsrådets förordning om undantag vid uttagande av självriskandelen som avses i 5 kapitlet 9 § 5 mom. i sjukförsäkringslagen
For reimbursement calculations under the cited health insurance rules, the drug-specific self-risk share is charged exceptionally for listed medicines used for long-term treatment, for an amount equal to three months of treatment even if bought in several partial purchases.
AI-assisted research synopsis — verify against the official legal text below.
- Jurisdiction
- Finland
- Instrument
- Regulation
- Citation
- 199
- Version
- Undated source snapshot
- Language
- sv
- Official source
- View official record ↗
Publicly available, excluded from search-engine indexing
This page remains available for direct access and API use, but this release emits
noindex,follow for the following reason:
- The record does not meet this release's canonical indexing criteria.
(market-indexing-disabled)
Statute overview
About this statute
For reimbursement calculations under the cited health insurance rules, the drug-specific self-risk share is charged exceptionally for listed medicines used for long-term treatment, for an amount equal to three months of treatment even if bought in several partial purchases. The drug-specific deductible may exceptionally be charged when reimbursement is calculated for certain medicines, if the medicines were obtained through several partial purchases during a three-month treatment period and dose dispensing was carried out under the cited health insurance rules. Förordningen träder i kraft den 1 april 2009. Åtgärder som behövs för verkställigheten får vidtas innan dess. En tidigare statsrådsförordning upphävs genom denna förordning.
Available versions
Undated version · current
fi
Undated version · current
sv
Ask AI about this statute
Statsrådets förordning om undantag vid uttagande av självriskandelen som avses i 5 kapitlet 9 § 5 mom. i sjukförsäkringslagen
Sign in to ask AI about this statute
Sign in to start authenticated, citation-grounded statute research.
Sign in